3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uveal Melanoma
6
Retinal Diseases
2
Melanoma
2
Macular Edema
2
von Hippel-Lindau Disease
1
Retinoblastoma
1
Neurofibromatosis 1
1
Neurofibroma
1
Neoplasms
1
Macular Degeneration
1
Glaucoma, Neovascular
1
Conjunctival Neoplasms
1
Choroid Diseases
1
Interventions
salicylhydroxamic acid
1
brolucizumab
1
aflibercept
1
Triamcinolone Acetonide
1
Ranibizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Macular Degeneration
×
Ranibizumab
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled